由JAK2 / STAT3途径调节的线粒体功能障碍导致细胞在帕图林暴露下死亡
Yun Liu1, Ruhan Yi1, Xu Zhang1
1Department of Food Nutrition and Safety, Dalian Medical University, No. 9W. Lushun South Road, Dalian 116044, China.
Ecotoxicology and environmental safety
|April 18, 2025
概括
帕图林 (PAT) 菌毒素通过亡引起损伤,涉及JAK2 / STAT3信号和线粒体功能障碍. 抑制这些通路可能为PAT中毒提供治疗策略.
科学领域:
- 毒理学 毒理学 毒理学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 帕图林 (PAT) 是一种在食品和农产品中普遍存在的真菌毒素.
- PAT在动物和人类中表现出有毒作用,具有毒性潜力.
- 导致PAT诱导的损伤的精确分子机制需要进一步研究.
研究的目的:
- 为了阐明PAT诱导的毒性机制.
- 调查死细胞灭绝,JAK2 / STAT3信号传递和线粒体功能障碍在PAT毒性的作用.
- 探索对PAT中毒的潜在治疗干预措施.
主要方法:
- 在体内研究评估损伤和亡标志物.
- 在体外实验中使用MPC-5细胞来确认分子通路.
- 使用特定抑制剂 (Nec-1,si-STAT3) 和药理学剂 (SS-31) 来评估保护作用.
主要成果:
- 暴露于PAT损害了淋巴细胞底膜的完整性,并在体内诱导了亡.
- PAT上调关键的亡相关蛋白质 (RIPK1,RIPK3,MLKL) 和JAK2/STAT3信号通路的组成部分.
- 抑制亡 (Nec-1) 或STAT3 (si-STAT3) 减少细胞死亡和改善线粒体功能.
- 用SS-31减弱的PAT诱导的亡来对线粒体进行药理保护.
结论:
- STAT3激活和线粒体功能障碍是PAT诱导亡的关键调解者.
- 这项研究揭示了涉及PAT毒性分子通路.
- 研究结果表明,针对PAT中毒的STAT3和线粒体功能的新型治疗策略.
相关概念视频
Necrosis
3.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.6K
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Overview of Cell Death
5.6K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
5.6K


